The Ticker

Feds shut down 
Maine shrimp season

Federal regulators shut down the commercial fishing season for northern shrimp in the Gulf of Maine for a second straight year yesterday, citing concerns about the declining population and warmer ocean temperatures.

The Atlantic States Marine Fisheries Commission's Northern Shrimp Section voted to cancel the up­coming season, a year after the section closed this year's season for the first time in more than 30 years.

The "depleted condition of the resource and poor prospects for the near future" warrant another closure, the committee reported, adding that "long term trends in environmental conditions" for the little pink shrimp are unfavorable. The amount of the shrimp's population that can be fished is at an all-time low, regulators said.

Wanderu raises $5.6 million

Boston startup Wanderu has raised $5.6 million in venture financing, the company announced yesterday.

Wanderu has created a way to find the cheapest bus tickets — similar to Orbitz or Kayak — in one place. The company said it will use the money to continue its expansion around the country.

The round of funding was led by Metamorphic Ventures and included Craig Lentzsch, former Greyhound CEO.

Celtics, Sun Life team up for diabetes

The Boston Celtics and Sun Life Financial are teaming up to promote diabetes prevention.

Sun Life will donate $1,000 to the YMCA dia­betes prevention program for every dunk by the Celtics this month. The company will also donate $1 for every tweet that uses the hashtag #SunLifeDunkFor Diabetes.­

TODAY

• Labor Department releases third-quarter productivity data, weekly jobless claims.
• Selected chain retailers release October sales.

TOMORROW

• Labor Department releases employment data for October.
• ROI Corp., a leading business brokerage firm in the Greater Boston area, announced the appointment of Julia Rayberg of Rockland as senior marketing associate. She will coordinate the growing firm's internal and external marketing efforts.
• BIND Therapeutics Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins, announced the appointment of Hagop Youssoufian, M.Sc., M.D., as chief medical officer. Youssoufian will be responsible for overseeing the clinical development and operations of BIND's internal pipeline.

Anda sedang membaca artikel tentang

The Ticker

Dengan url

http://sedangapasaja.blogspot.com/2014/11/the-ticker_6.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

The Ticker

namun jangan lupa untuk meletakkan link

The Ticker

sebagai sumbernya